These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2903170)

  • 1. The effects of sodium valproate on plasma somatostatin and insulin in humans.
    Kusunoki M; Yamamura T; Ichii S; Fujita S; Nakai T; Utsunomiya J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1060-3. PubMed ID: 2903170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
    Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
    J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose turnover and gluconeogenesis in a patient with somatostatinoma.
    Lowry SF; Burt ME; Brennan MF
    Surgery; 1981 Mar; 89(3):309-13. PubMed ID: 6110246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of magnesium valproate on plasma ACTH concentrations in Nelson's syndrome.
    Kasperlik-Załuska A; Migdalska B; Jeske W; Drac-Kaniewska J; Wiśniewska-Woźniak T
    Acta Med Pol; 1989; 30(1-2):9-15. PubMed ID: 2562233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men.
    Coiro V; Capretti L; Bianconi L; Castelli A; Cerri L; Roberti G; Marcato A; Volpi R; Chiodera P
    Horm Metab Res; 1991 Dec; 23(12):600-4. PubMed ID: 1663914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variation in glucose tolerance and associated changes in plasma insulin and somatostatin levels in normal volunteers.
    Verrillo A; de Teresa A; Rucco E
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2261-6. PubMed ID: 6152172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man.
    Cavagnini F; Pinto M; Dubini A; Invitti C; Cappelletti G; Polli EE
    Metabolism; 1982 Jan; 31(1):73-7. PubMed ID: 7043162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.
    Schusdziarra V; Grube D; Seifert H; Galle J; Etzrodt H; Beischer W; Haferkamp O; Pfeiffer EF
    Klin Wochenschr; 1983 Jul; 61(14):681-9. PubMed ID: 6136627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity.
    Baldino F; Geller HM
    J Pharmacol Exp Ther; 1981 May; 217(2):445-50. PubMed ID: 6785416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin on plasma C-peptide immunoreactivity in normal man.
    Canivet J; Brisson C; Gauvillé C
    Diabete Metab; 1977 Jun; 3(2):109-12. PubMed ID: 892126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
    J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
    Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
    Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic polypeptide in somatostatinoma.
    Pinsard D; Odent S; Chadenas D
    Dig Dis Sci; 1986 Apr; 31(4):445-6. PubMed ID: 2869926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endogenous levels of somatostatin, C-peptide and insulin in acute pancreatitis].
    Aleryani S; Huorka M; Payer J; Duris I; Ondrejka P; Kratochvíl'ová H
    Vnitr Lek; 1997 Nov; 43(11):733-7. PubMed ID: 9650504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.